Rankings
▼
Calendar
BDSX Q3 2019 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena
BDSX
Biodesix, Inc.
$138M
Q3 2019 Earnings
Healthcare
Medical - Diagnostics & Research
Income Statement
Revenue
$4M
Gross Profit
$2M
61.9% margin
Operating Income
-$9M
-229.0% margin
Net Income
-$10M
-243.6% margin
EPS (Diluted)
$-7.23
QoQ Revenue Growth
-36.1%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$45,000
← FY 2019
All Quarters
Q4 2019 →